{"DataElement":{"publicId":"13368774","version":"1","preferredName":"Measurable Residual Disease Molecular Marker Type","preferredDefinition":"The type of molecular characteristics that are used as a biomarker for minimal residual disease.","longName":"13336633v1.00:13336577v1.00","context":"Pediatric Cancer","contextVersion":"1","DataElementConcept":{"publicId":"13336633","version":"1","preferredName":"Measurable Residual Disease Molecular Marker","preferredDefinition":"Evidence for remaining tumor following primary treatment that is only apparent using highly sensitive techniques.:A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.","longName":"2452232v1.00:2437715v1.00","context":"Pediatric Cancer","contextVersion":"1","ObjectClass":{"publicId":"2452232","version":"1","preferredName":"Minimal Residual Disease","preferredDefinition":"remainder of a tumor or a neoplasm/cancer after primary, potentially curative therapy.","longName":"C3896","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Measurable Residual Disease","conceptCode":"C3896","definition":"Evidence for remaining tumor following primary treatment that is only apparent using highly sensitive techniques.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D052842-7AD9-4FD3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-22","modifiedBy":"ONEDATA","dateModified":"2006-02-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2437715","version":"1","preferredName":"Biomarker","preferredDefinition":"Objectively measurable phenotypic parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype, presence of biological substances) that characterize an organism's state of health or disease, likelihood of developing a disease, or response to a particular therapeutic intervention.","longName":"C16342","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biomarker","conceptCode":"C16342","definition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07F9A427-79F8-5E87-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-15","endDate":null,"createdBy":"UMLLOADER_CAMOD","dateCreated":"2005-12-15","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FFB5C4-3EA4-18AF-E053-731AD00AAFBF","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"JKNABLE","dateCreated":"2023-04-10","modifiedBy":"FINCHAMB","dateModified":"2023-11-14","changeDescription":null,"administrativeNotes":"11/14/23 Released per PCDC-U of Chicago/Mei Li. BF;7/24/23 Upd OC and property. mr; \r\n4/24/2023: added Origin to DEC.wz","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"13336577","version":"1","preferredName":"Molecular Marker Type","preferredDefinition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention._Something distinguishable as an identifiable class based on common qualities.","longName":"13336577v1.00","context":"Pediatric Cancer","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"inv(3)(q21;q21.2)","valueDescription":null,"ValueMeaning":{"publicId":"7292242","version":"1","preferredName":"inv(3)(q21.3;q26.2)","longName":"7292242v1.00","preferredDefinition":"A cytogenetic abnormality that refers to a paracentric inversion involving breakpoints on the long (q23.1 and q26.2) of chromosome 3. It is associated with acute myeloid leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"inv(3)(q21.3;q26.2)","conceptCode":"C36407","definition":"A cytogenetic abnormality that refers to a paracentric inversion involving breakpoints on the long (q23.1 and q26.2) of chromosome 3. It is associated with acute myeloid leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A58D6648-C099-77DB-E053-F662850A458B","latestVersionIndicator":"Yes","beginDate":"2020-05-13","endDate":null,"createdBy":"COLBERTM","dateCreated":"2020-05-13","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE90FD-2B3F-62F6-E053-731AD00AC5F6","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"K-RAS mutation","valueDescription":null,"ValueMeaning":{"publicId":"4514746","version":"1","preferredName":"KRAS Gene Mutation","longName":"4514746","preferredDefinition":"A change in the nucleotide sequence of the KRAS gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KRAS Gene Mutation","conceptCode":"C41361","definition":"A change in the nucleotide sequence of the KRAS gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7CD7-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"FINCHAMB","dateModified":"2023-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE90FD-2B40-62F6-E053-731AD00AC5F6","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"MLL Other partner","valueDescription":null,"ValueMeaning":{"publicId":"3554905","version":"1","preferredName":"Translocation 11q23","longName":"3554905v1.00","preferredDefinition":"A chromosomal abnormality consisting of the translocation of genetic material from any one of several chromosomes to the 11q23.3 region, resulting in an MLL gene rearrangement.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(v;11q23.3)","conceptCode":"C36517","definition":"A chromosomal abnormality consisting of the translocation of genetic material from any one of several chromosomes to the 11q23.3 region, resulting in an MLL gene rearrangement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C740F5C7-76D8-BDA9-E040-BB89AD434D2D","latestVersionIndicator":"Yes","beginDate":"2012-08-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-14","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE90FD-2B41-62F6-E053-731AD00AC5F6","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"Monosomy 5","valueDescription":null,"ValueMeaning":{"publicId":"3743421","version":"1","preferredName":"Monosomy 5","longName":"3743421","preferredDefinition":"A cytogenetic aneuploidy abnormality that refers to the presence of one chromosome 5 only. It is associated with the development of refractory anemia with excess blasts, refractory anemia with multilineage dysplasia, and refractory anemia with multilineage dysplasia and ringed sideroblasts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Monosomy 5","conceptCode":"C36523","definition":"A cytogenetic aneuploidy abnormality that refers to the presence of one chromosome 5 only. It is associated with the development of refractory anemia with excess blasts, refractory anemia with multilineage dysplasia, and refractory anemia with multilineage dysplasia and ringed sideroblasts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBD4B1B6-9860-7B0B-E040-BB89AD436F3F","latestVersionIndicator":"Yes","beginDate":"2013-05-03","endDate":null,"createdBy":"COLBERTM","dateCreated":"2013-05-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE90FD-2B42-62F6-E053-731AD00AC5F6","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"Monosomy 7","valueDescription":null,"ValueMeaning":{"publicId":"2762295","version":"1","preferredName":"Monosomy 7","longName":"2762295","preferredDefinition":"A chromosomal abnormality consisting of the absence of one of the copies of chromosome 7 in somatic cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Monosomy 7","conceptCode":"C36411","definition":"A chromosomal abnormality consisting of the absence of one of the copies of chromosome 7 in somatic cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"510ADE83-0189-56CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"STURGILLJ","dateCreated":"2008-07-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE90FD-2B43-62F6-E053-731AD00AC5F6","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"N-RAS mutation","valueDescription":null,"ValueMeaning":{"publicId":"5509092","version":"1","preferredName":"NRAS Gene Mutation","longName":"5509092","preferredDefinition":"A change in the structure of the NRAS gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NRAS Gene Mutation","conceptCode":"C41381","definition":"A change in the structure of the NRAS gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E984DAC-540A-3B8C-E053-F662850ABB84","latestVersionIndicator":"Yes","beginDate":"2016-10-11","endDate":null,"createdBy":"COLBERTM","dateCreated":"2016-10-11","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE90FD-2B44-62F6-E053-731AD00AC5F6","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"non-KMT2A MLLT10","valueDescription":null,"ValueMeaning":{"publicId":"13336600","version":"1","preferredName":"Non-KMT2A MLLT10 Rearrangement Positive","longName":"13336600v1.00","preferredDefinition":"An indication that a cytogenetic rearrangement involving MLLT10 but not involving KMT2A was detected in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-KMT2A MLLT10 Rearrangement Positive","conceptCode":"C168771","definition":"An indication that a cytogenetic rearrangement involving MLLT10 but not involving KMT2A was detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE90FD-2B3B-62F6-E053-731AD00AC5F6","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE90FD-2B45-62F6-E053-731AD00AC5F6","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"NPM1 mutation","valueDescription":null,"ValueMeaning":{"publicId":"5509772","version":"1","preferredName":"NPM1 Gene Mutation","longName":"5509772","preferredDefinition":"Mutation of the nucleophosmin gene. It is seen in acute myeloid leukemias usually associated with a normal karyotype.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NPM1 Gene Mutation","conceptCode":"C82429","definition":"Mutation of the nucleophosmin gene. It is seen in acute myeloid leukemias usually associated with a normal karyotype.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3EAE8FC9-F8B7-6B59-E053-F662850AD453","latestVersionIndicator":"Yes","beginDate":"2016-10-12","endDate":null,"createdBy":"COLBERTM","dateCreated":"2016-10-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE90FD-2B46-62F6-E053-731AD00AC5F6","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"PTPN11 mutation","valueDescription":null,"ValueMeaning":{"publicId":"5907475","version":"1","preferredName":"PTPN11 Gene Mutation","longName":"5907475","preferredDefinition":"Mutation of the protein tyrosine phosphatase, non-receptor type 11 gene. It is seen in cases of juvenile myelomonocytic leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PTPN11 Gene Mutation","conceptCode":"C82612","definition":"Mutation of the protein tyrosine phosphatase, non-receptor type 11 gene. It is seen in cases of juvenile myelomonocytic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54226B98-B9DD-5F1A-E053-F662850AE2A6","latestVersionIndicator":"Yes","beginDate":"2017-07-12","endDate":null,"createdBy":"COLBERTM","dateCreated":"2017-07-12","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE90FD-2B47-62F6-E053-731AD00AC5F6","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"t(1;11)(q21;q23) / MLL-MLLT11(AF1Q)","valueDescription":null,"ValueMeaning":{"publicId":"13336601","version":"1","preferredName":"t(1;11)(q21;q23)","longName":"13336601v1.00","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of the long arm (q21) of chromosome 1 and the long arm (q23) of chromosome 11. It is associated with KMT2A (MLL)/MLLT11 (AF1Q) fusions, acute myeloid leukemia and some cases of acute lymphoblastic leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(1;11)(q21;q23)","conceptCode":"C168759","definition":"A cytogenetic abnormality that refers to the translocation of the long arm (q21) of chromosome 1 and the long arm (q23) of chromosome 11. It is associated with KMT2A (MLL)/MLLT11 (AF1Q) fusions, acute myeloid leukemia and some cases of acute lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE90FD-2B3C-62F6-E053-731AD00AC5F6","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE90FD-2B48-62F6-E053-731AD00AC5F6","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"t(1;22)(RBM15-MKL1)","valueDescription":null,"ValueMeaning":{"publicId":"13336602","version":"1","preferredName":"t(1;22)(p13.3;q13.1)","longName":"13336602v1.00","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of the short arm (p13.3) of chromosome 1 and the long arm (q13.1) of chromosome 22. It is associated with RBM15/MRTFA (MKL1) fusions and acute megakaryocytic leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(1;22)(p13.3;q13.1)","conceptCode":"C36417","definition":"A cytogenetic abnormality that refers to the translocation of the short arm (p13.3) of chromosome 1 and the long arm (q13.1) of chromosome 22. It is associated with RBM15/MRTFA (MKL1) fusions and acute megakaryocytic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE90FD-2B3D-62F6-E053-731AD00AC5F6","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE90FD-2B49-62F6-E053-731AD00AC5F6","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"t(10;11)(p11.2;q23)","valueDescription":null,"ValueMeaning":{"publicId":"13336603","version":"1","preferredName":"t(10;11)(p11.2;q23)","longName":"13336603v1.00","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of the short arm (p11.2) of chromosome 10 and the long arm (q23) of chromosome 11. It is associated with KMT2A (MLL)/ABI1 fusions and acute myeloid leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(10;11)(p11.2;q23)","conceptCode":"C168758","definition":"A cytogenetic abnormality that refers to the translocation of the short arm (p11.2) of chromosome 10 and the long arm (q23) of chromosome 11. It is associated with KMT2A (MLL)/ABI1 fusions and acute myeloid leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE90FD-2B3E-62F6-E053-731AD00AC5F6","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE90FD-2B4A-62F6-E053-731AD00AC5F6","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"t(10;11)(p12;q23) / MLL-MLLT10(AF10)","valueDescription":null,"ValueMeaning":{"publicId":"5709220","version":"1","preferredName":"t(10;11)(p12;q23)","longName":"5709220","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of chromosome 10p12 with chromosome 11q23. It is associated with acute myeloid leukemia in childhood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(10;11)(p12;q23)","conceptCode":"C132102","definition":"A cytogenetic abnormality that refers to the translocation of chromosome 10p12 with chromosome 11q23. It is associated with acute myeloid leukemia in childhood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A9E460A-03CD-1810-E053-F662850AD355","latestVersionIndicator":"Yes","beginDate":"2017-03-13","endDate":null,"createdBy":"COLBERTM","dateCreated":"2017-03-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE90FD-2B4B-62F6-E053-731AD00AC5F6","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"RUNX1 mutation","valueDescription":null,"ValueMeaning":{"publicId":"6438453","version":"1","preferredName":"RUNX1 Gene Mutation","longName":"6438453","preferredDefinition":"A change in the nucleotide sequence of the RUNX1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"RUNX1 Gene Mutation","conceptCode":"C38362","definition":"A change in the nucleotide sequence of the RUNX1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76C9F568-A237-2E22-E053-F662850A228A","latestVersionIndicator":"Yes","beginDate":"2018-09-26","endDate":null,"createdBy":"COLBERTM","dateCreated":"2018-09-26","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE90FD-2B4C-62F6-E053-731AD00AC5F6","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"del(17p)","valueDescription":null,"ValueMeaning":{"publicId":"4534971","version":"1","preferredName":"Loss of Chromosome 17p","longName":"4534971","preferredDefinition":"A cytogenetic abnormality that refers to the allelic loss of all or part of the short arm of chromosome 17.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Loss of Chromosome 17p","conceptCode":"C36499","definition":"A cytogenetic abnormality that refers to the loss of all or part of the short arm of chromosome 17 (17p).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05633FB3-FD67-B268-E050-BB89AD431E51","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE90FD-2B4D-62F6-E053-731AD00AC5F6","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"del(5q)(5q31-q32)","valueDescription":null,"ValueMeaning":{"publicId":"13336598","version":"1","preferredName":"del(5q31-q32)","longName":"13336598v1.00","preferredDefinition":"A cytogenetic abnormality that refers to deletion of chromosome bands 31-32 on the long arm of chromosome 5.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"del(5q31-q32)","conceptCode":"C168769","definition":"A cytogenetic abnormality that refers to deletion of chromosome bands 31-32 on the long arm of chromosome 5.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE90FD-2B39-62F6-E053-731AD00AC5F6","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE90FD-2B4E-62F6-E053-731AD00AC5F6","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"der.12p","valueDescription":null,"ValueMeaning":{"publicId":"13336599","version":"1","preferredName":"der12p","longName":"13336599v1.00","preferredDefinition":"A cytogenetic abnormality involving the rearrangement of two or more other chromosomes with the short arm of chromosome 12 (12p).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"der12p","conceptCode":"C173542","definition":"A cytogenetic abnormality involving the rearrangement of two or more other chromosomes with the short arm of chromosome 12 (12p).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE90FD-2B3A-62F6-E053-731AD00AC5F6","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE90FD-2B4F-62F6-E053-731AD00AC5F6","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"FLT3 internal tandem duplication","valueDescription":null,"ValueMeaning":{"publicId":"3630974","version":"1","preferredName":"FLT3 Internal Tandem Duplication","longName":"3630974","preferredDefinition":"A genetic abnormality that arises from duplications of the juxtamembrane portion of the gene and results in constitutive activation of the FLT3 receptor tyrosine kinase protein in early hematopoietic progenitor cells. It is associated with acute myelogenous leukemia where it appears to correlate with a poor prognosis.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FLT3 Internal Tandem Duplication","conceptCode":"C67494","definition":"A genetic abnormality that arises from duplications of the juxtamembrane portion of the gene and results in constitutive activation of the FLT3 receptor tyrosine kinase protein in early hematopoietic progenitor cells. It is associated with acute myelogenous leukemia where it appears to correlate with a poor prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CF94B6E0-9B06-7FAD-E040-BB89AD433160","latestVersionIndicator":"Yes","beginDate":"2012-11-28","endDate":null,"createdBy":"LEUNGE","dateCreated":"2012-11-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE90FD-2B50-62F6-E053-731AD00AC5F6","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"FLT3-TKD","valueDescription":null,"ValueMeaning":{"publicId":"3925972","version":"1","preferredName":"Flt3 Ligand Point Mutation","longName":"3925972","preferredDefinition":"Single nucleotide mutations in the tyrosine kinase domain encoded by the human FLT3 gene that are associated with acute myeloid leukemia and poor prognosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FLT3 Tyrosine Kinase Domain Point Mutation","conceptCode":"C67495","definition":"Single nucleotide mutations in the tyrosine kinase domain encoded by the human FLT3 gene that are associated with acute myeloid leukemia and poor prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9563CDD-9016-A3C4-E040-BB89AD431C3A","latestVersionIndicator":"Yes","beginDate":"2013-10-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE90FD-2B51-62F6-E053-731AD00AC5F6","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"GATA1 mutation","valueDescription":null,"ValueMeaning":{"publicId":"6450706","version":"1","preferredName":"GATA1 Gene Mutation","longName":"6450706","preferredDefinition":"A change in the nucleotide sequence of the GATA1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"GATA1 Gene Mutation","conceptCode":"C82340","definition":"A change in the nucleotide sequence of the GATA1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76F29E01-0285-57FB-E053-F662850A7BC0","latestVersionIndicator":"Yes","beginDate":"2018-09-28","endDate":null,"createdBy":"COLBERTM","dateCreated":"2018-09-28","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE90FD-2B52-62F6-E053-731AD00AC5F6","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"inv(16)(p13.3q24.3)/CBFA2T3-GLIS2","valueDescription":null,"ValueMeaning":{"publicId":"7292219","version":"1","preferredName":"inv(16)(p13.3;q24.3)","longName":"7292219","preferredDefinition":"A pericentric chromosomal inversion that involves chromosome 16. It is associated with CBFA2T3/GLIS2 fusions and pediatric acute megakaryoblastic leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"inv(16)(p13.3;q24.3)","conceptCode":"C167195","definition":"A pericentric chromosomal inversion that involves chromosome 16. It is associated with CBFA2T3/GLIS2 fusions and pediatric acute megakaryoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A58CF713-0A52-2632-E053-F662850ABD95","latestVersionIndicator":"Yes","beginDate":"2020-05-13","endDate":null,"createdBy":"COLBERTM","dateCreated":"2020-05-13","modifiedBy":"COLBERTM","dateModified":"2020-06-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE90FD-2B53-62F6-E053-731AD00AC5F6","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"inv(16)(p13q22)","valueDescription":null,"ValueMeaning":{"publicId":"4340488","version":"1","preferredName":"inv(16)(p13.1q22)","longName":"4340488","preferredDefinition":"A chromosomal inversion that involves chromosome 16. It is associated with the development of acute myeloid leukemia CBFB-MYH11, acute myelomonocytic leukemia with abnormal eosinophils, and granulocytic sarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"inv(16)(p13.1;q22)","conceptCode":"C36373","definition":"A chromosomal inversion that involves chromosome 16. It is associated with the development of acute myeloid leukemia CBFB-MYH11, acute myelomonocytic leukemia with abnormal eosinophils, and granulocytic sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FADC8D24-9CFA-C9E3-E040-BB89AD4350B8","latestVersionIndicator":"Yes","beginDate":"2014-06-02","endDate":null,"createdBy":"COLBERTM","dateCreated":"2014-06-02","modifiedBy":"COLBERTM","dateModified":"2020-05-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE90FD-2B54-62F6-E053-731AD00AC5F6","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"Any MLL rearrangement","valueDescription":null,"ValueMeaning":{"publicId":"5540277","version":"1","preferredName":"MLL Gene Rearrangement","longName":"5540277","preferredDefinition":"A molecular abnormality indicating rearrangement of the MLL (KMT2A) gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KMT2A Gene Rearrangement","conceptCode":"C122623","definition":"A molecular abnormality indicating rearrangement of the KMT2A (MLL) gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FA1F895-F0FB-05B5-E053-F662850AA504","latestVersionIndicator":"Yes","beginDate":"2016-10-24","endDate":null,"createdBy":"COLBERTM","dateCreated":"2016-10-24","modifiedBy":"ONEDATA_WA","dateModified":"2023-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE90FD-2B55-62F6-E053-731AD00AC5F6","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"CEBPA mutation - biallelic","valueDescription":null,"ValueMeaning":{"publicId":"6648963","version":"1","preferredName":"Biallelic CEBPA Gene Mutation","longName":"6648963","preferredDefinition":"The presence of mutations in both alleles of the CEBPA gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biallelic CEBPA Gene Mutation","conceptCode":"C157569","definition":"The presence of mutations in both alleles of the CEBPA gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"822D97FE-719A-7DAB-E053-F662850A072D","latestVersionIndicator":"Yes","beginDate":"2019-02-18","endDate":null,"createdBy":"COLBERTM","dateCreated":"2019-02-18","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE90FD-2B56-62F6-E053-731AD00AC5F6","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"CEBPA mutation - monoallelic","valueDescription":null,"ValueMeaning":{"publicId":"13336596","version":"1","preferredName":"Monoallelic CEBPA Gene Mutation","longName":"13336596v1.00","preferredDefinition":"The presence of mutations in only one allele of the CEBPA gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Monoallelic CEBPA Gene Mutation","conceptCode":"C168774","definition":"The presence of mutations in only one allele of the CEBPA gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE90FD-2B37-62F6-E053-731AD00AC5F6","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE90FD-2B57-62F6-E053-731AD00AC5F6","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"CEBPA mutation - mutation unspecified","valueDescription":null,"ValueMeaning":{"publicId":"6450506","version":"1","preferredName":"CEBPA Gene Mutation","longName":"6450506","preferredDefinition":"Mutation of the CEBPA gene encoding CCAAT/enhancer binding protein alpha. It is seen in acute myeloid leukemias usually associated with a normal karyotype.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CEBPA Gene Mutation","conceptCode":"C38372","definition":"Mutation of the CEBPA gene encoding CCAAT/enhancer binding protein alpha. It is seen in acute myeloid leukemias usually associated with a normal karyotype.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76EF893C-D0EC-5805-E053-F662850A9F76","latestVersionIndicator":"Yes","beginDate":"2018-09-28","endDate":null,"createdBy":"COLBERTM","dateCreated":"2018-09-28","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE90FD-2B58-62F6-E053-731AD00AC5F6","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"CKIT mutation - ex17","valueDescription":null,"ValueMeaning":{"publicId":"5002154","version":"1","preferredName":"Seventeen KIT Gene Exon","longName":"5002154","preferredDefinition":"A molecular genetic abnormality indicating the presence of a mutation in exon 17 of the KIT gene located within 4q11-q12.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KIT Exon 17 Mutation","conceptCode":"C116396","definition":"A molecular genetic abnormality indicating the presence of a mutation in exon 17 of the KIT gene located within 4q11-q12.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1EF08B88-09CC-350D-E050-BB89AD434618","latestVersionIndicator":"Yes","beginDate":"2015-09-04","endDate":null,"createdBy":"COLBERTM","dateCreated":"2015-09-04","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE90FD-2B59-62F6-E053-731AD00AC5F6","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"CKIT mutation - ex8","valueDescription":null,"ValueMeaning":{"publicId":"5002155","version":"1","preferredName":"Eight KIT Gene Exon","longName":"5002155","preferredDefinition":"A molecular genetic abnormality indicating the presence of a mutation in exon 8 of the KIT gene located within 4q11-q12.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KIT Exon 8 Mutation","conceptCode":"C128660","definition":"A molecular genetic abnormality indicating the presence of a mutation in exon 8 of the KIT gene located within 4q11-q12.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1EF08B88-09F3-350D-E050-BB89AD434618","latestVersionIndicator":"Yes","beginDate":"2015-09-04","endDate":null,"createdBy":"COLBERTM","dateCreated":"2015-09-04","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE90FD-2B5A-62F6-E053-731AD00AC5F6","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"CKIT mutation - unspecified","valueDescription":null,"ValueMeaning":{"publicId":"4514717","version":"1","preferredName":"KIT Gene Mutation","longName":"4514717","preferredDefinition":"A molecular genetic abnormality that refers to mutation of the c-kit (CD117) proto-oncogene. It is associated with the development of gastrointestinal stromal tumor and gastrointestinal autonomic nerve tumor. It has also been described in acute myeloid leukemias, dysgerminomas, and seminomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KIT Gene Mutation","conceptCode":"C39712","definition":"A molecular genetic abnormality that refers to mutation of the c-kit (CD117) proto-oncogene. It is associated with the development of gastrointestinal stromal tumor and gastrointestinal autonomic nerve tumor. It has also been described in acute myeloid leukemias, dysgerminomas, and seminomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7A18-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE90FD-2B5B-62F6-E053-731AD00AC5F6","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"del(13q) (13q 14 - 21)","valueDescription":null,"ValueMeaning":{"publicId":"13336597","version":"1","preferredName":"del(13q14-q21)","longName":"13336597v1.00","preferredDefinition":"A cytogenetic abnormality that refers to deletion of chromosome bands 14-21 on the long arm of chromosome 13.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"del(13q14-q21)","conceptCode":"C168770","definition":"A cytogenetic abnormality that refers to deletion of chromosome bands 14-21 on the long arm of chromosome 13.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE90FD-2B38-62F6-E053-731AD00AC5F6","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE90FD-2B5C-62F6-E053-731AD00AC5F6","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"t(3;12)(q23;p12.3)(ETV6/EVI1)","valueDescription":null,"ValueMeaning":{"publicId":"13336610","version":"1","preferredName":"t(3;12)(q23;p12.3)","longName":"13336610v1.00","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of the long arm (q23) of chromosome 3 and the short arm (p12.3) of chromosome 12. It is associated with ETV6/MECOM (EVI1) fusions, myeloproliferative disorders, myelodysplastic syndromes and acute myelogenous leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(3;12)(q23;p12.3)","conceptCode":"C168766","definition":"A cytogenetic abnormality that refers to the translocation of the long arm (q23) of chromosome 3 and the short arm (p12.3) of chromosome 12. It is associated with ETV6/MECOM (EVI1) fusions, myeloproliferative disorders, myelodysplastic syndromes and acute myelogenous leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE98B7-42F9-63DD-E053-731AD00A57C2","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE98B7-42FD-63DD-E053-731AD00A57C2","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"t(3;3)(q21;q26.2)","valueDescription":null,"ValueMeaning":{"publicId":"7292221","version":"1","preferredName":"t(3;3)(q21.3;q26.2)","longName":"7292221","preferredDefinition":"A cytogenetic abnormality that refers to the translocation where both breakpoints are on the long arm (q23.1 and q26.2) of chromosome 3. It is associated with acute myeloid leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(3;3)(q21.3;q26.2)","conceptCode":"C36406","definition":"A cytogenetic abnormality that refers to the translocation where both breakpoints are on the long arm (q23.1 and q26.2) of chromosome 3. It is associated with acute myeloid leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A58CF713-0A78-2632-E053-F662850ABD95","latestVersionIndicator":"Yes","beginDate":"2020-05-13","endDate":null,"createdBy":"COLBERTM","dateCreated":"2020-05-13","modifiedBy":"COLBERTM","dateModified":"2020-06-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE98B7-42FE-63DD-E053-731AD00A57C2","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"t(3;5)(q25;q34)NPM1/MLF1","valueDescription":null,"ValueMeaning":{"publicId":"7292216","version":"1","preferredName":"t(3;5)(q25;q34)","longName":"7292216","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of the long arm (q25) of chromosome 3 and the long arm (q34) of chromosome 5. It is associated with the development of acute myeloid leukemia arising from myelodysplastic syndrome, acute myeloid leukemia with multilineage dysplasia, and acute myeloid leukemia with myelodysplasia-related changes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(3;5)(q25;q34)","conceptCode":"C36415","definition":"A cytogenetic abnormality that refers to the translocation of the long arm (q25) of chromosome 3 and the long arm (q34) of chromosome 5. It is associated with the development of acute myeloid leukemia arising from myelodysplastic syndrome, acute myeloid leukemia with multilineage dysplasia, and acute myeloid leukemia with myelodysplasia-related changes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A58CF713-09E3-2632-E053-F662850ABD95","latestVersionIndicator":"Yes","beginDate":"2020-05-13","endDate":null,"createdBy":"COLBERTM","dateCreated":"2020-05-13","modifiedBy":"ONEDATA","dateModified":"2020-05-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE98B7-42FF-63DD-E053-731AD00A57C2","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"t(4;11)(q21;q23) / MLL-MLLT2(AF4)","valueDescription":null,"ValueMeaning":{"publicId":"6333811","version":"1","preferredName":"t(4;11)(q21;q23)","longName":"6333811","preferredDefinition":"A chromosomal abnormality consisting of the translocation of 4q21 with 11q23.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(4;11)(q21;q23.3)","conceptCode":"C36365","definition":"A chromosomal abnormality consisting of the translocation of 4q21 with 11q23.3.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E5F13B2-C579-1BBA-E053-F662850A0842","latestVersionIndicator":"Yes","beginDate":"2018-06-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2018-06-11","modifiedBy":"ONEDATA_WA","dateModified":"2023-06-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE98B7-4300-63DD-E053-731AD00A57C2","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"t(5;11)(q35;p15) NSD1/NUP98","valueDescription":null,"ValueMeaning":{"publicId":"13336611","version":"1","preferredName":"t(5;11)(q35;p15)","longName":"13336611v1.00","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of chromosome 11p15 with chromosome 5q35. It results in the formation of NUP98/NSD1 fusion gene. It is associated with the development of acute myeloid leukemia with t(5;11)(q35;p15); NUP98-NSD1.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(5;11)(q35;p15)","conceptCode":"C131503","definition":"A cytogenetic abnormality that refers to the translocation of chromosome 11p15 with chromosome 5q35. It results in the formation of NUP98/NSD1 fusion gene. It is associated with the development of acute myeloid leukemia with t(5;11)(q35;p15); NUP98-NSD1.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE98B7-42FA-63DD-E053-731AD00A57C2","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE98B7-4301-63DD-E053-731AD00A57C2","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"t(6;11)(q27;q23) / MLL-MLLT4(AF6)","valueDescription":null,"ValueMeaning":{"publicId":"5709221","version":"1","preferredName":"t(6;11)(q27;q23)","longName":"5709221","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of the long arm (q27) of chromosome 6 and the long arm (q23) of chromosome 11. It is associated with the development of de novo acute myeloid leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(6;11)(q27;q23)","conceptCode":"C36610","definition":"A cytogenetic abnormality that refers to the translocation of the long arm (q27) of chromosome 6 and the long arm (q23) of chromosome 11. It is associated with the development of de novo acute myeloid leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A9E460A-03F2-1810-E053-F662850AD355","latestVersionIndicator":"Yes","beginDate":"2017-03-13","endDate":null,"createdBy":"COLBERTM","dateCreated":"2017-03-13","modifiedBy":"COLBERTM","dateModified":"2020-06-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE98B7-4302-63DD-E053-731AD00A57C2","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"t(6;9)(p23;q34) DEK/NUP214","valueDescription":null,"ValueMeaning":{"publicId":"7292218","version":"1","preferredName":"t(6;9)(p23;q34.1)","longName":"7292218v1.00","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of the short arm (p23) of chromosome 6 and the long arm (q34.1) of chromosome 9. It is associated with DEK/NUP214 fusions, acute myeloid leukemia and myelodysplastic syndromes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(6;9)(p22.3;q34.1)","conceptCode":"C36532","definition":"A cytogenetic abnormality that refers to the translocation of the short arm (p22.3) of chromosome 6 and the long arm (q34.1) of chromosome 9. It is associated with DEK/NUP214 fusions, acute myeloid leukemia and myelodysplastic syndromes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A58CF713-0A2D-2632-E053-F662850ABD95","latestVersionIndicator":"Yes","beginDate":"2020-05-13","endDate":null,"createdBy":"COLBERTM","dateCreated":"2020-05-13","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE98B7-4303-63DD-E053-731AD00A57C2","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"t(8;16)MOZ/CBP","valueDescription":null,"ValueMeaning":{"publicId":"7292244","version":"1","preferredName":"t(8;16)(p11.2;p13.3)","longName":"7292244","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of the short arm (p11.2) of chromosome 8 and the short arm (p13.3) of chromosome 16. It is associated with KAT6A/CREBBP fusions and acute myeloid leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(8;16)(p11.2;p13.3)","conceptCode":"C167194","definition":"A cytogenetic abnormality that refers to the translocation of the short arm (p11.2) of chromosome 8 and the short arm (p13.3) of chromosome 16. It is associated with KAT6A/CREBBP fusions and acute myeloid leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A58D6648-C0E3-77DB-E053-F662850A458B","latestVersionIndicator":"Yes","beginDate":"2020-05-13","endDate":null,"createdBy":"COLBERTM","dateCreated":"2020-05-13","modifiedBy":"COLBERTM","dateModified":"2020-06-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE98B7-4304-63DD-E053-731AD00A57C2","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"t(9;11)(p22;q23) / MLL-MLLT3(AF9)","valueDescription":null,"ValueMeaning":{"publicId":"13336613","version":"1","preferredName":"t(9;11)(p21.3;q23.3)","longName":"13336613v1.00","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of the short arm (p21.3) of chromosome 9 and the long arm (q23.3) of chromosome 11. It is associated with the development of acute myeloid leukemia with the MLLT3-MLL fusion gene transcript.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(9;11)(p21.3;q23.3)","conceptCode":"C36370","definition":"A cytogenetic abnormality that refers to the translocation of the short arm (p21.3) of chromosome 9 and the long arm (q23.3) of chromosome 11. It is associated with the development of acute myeloid leukemia with the MLLT3-MLL fusion gene transcript.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE98B7-42FC-63DD-E053-731AD00A57C2","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE98B7-4305-63DD-E053-731AD00A57C2","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"t(9;22)(q34;q11.2) ABL/BCR","valueDescription":null,"ValueMeaning":{"publicId":"2672728","version":"1","preferredName":"t(9;22)(q34;q11)","longName":"2672728v1.00","preferredDefinition":"A translocation between chromosomes 9 and 22 that is associated with the Philadelphia chromosome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(9;22)(q34.1;q11.2)","conceptCode":"C13271","definition":"A translocation between chromosomes 9 and 22 that is associated with the Philadelphia chromosome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"37BCDCA9-0A3F-297B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-15","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-15","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE98B7-4306-63DD-E053-731AD00A57C2","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"Trisomy 8","valueDescription":null,"ValueMeaning":{"publicId":"3554906","version":"1","preferredName":"Trisomy Chromosome 8","longName":"3554906","preferredDefinition":"A chromosomal abnormality consisting of the presence of a third copy of chromosome 8 in somatic cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Trisomy 8","conceptCode":"C36396","definition":"A chromosomal abnormality consisting of the presence of a third copy of chromosome 8 in somatic cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C740F5C7-76FE-BDA9-E040-BB89AD434D2D","latestVersionIndicator":"Yes","beginDate":"2012-08-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-14","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE98B7-4307-63DD-E053-731AD00A57C2","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"WT1 mutation","valueDescription":null,"ValueMeaning":{"publicId":"6068728","version":"1","preferredName":"WT1 Gene Mutation","longName":"6068728","preferredDefinition":"A change in the nucleotide sequence of the WT1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"WT1 Gene Mutation","conceptCode":"C146726","definition":"A change in the nucleotide sequence of the WT1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6519AB80-BED8-7F0F-E053-F662850A7B7E","latestVersionIndicator":"Yes","beginDate":"2018-02-13","endDate":null,"createdBy":"COLBERTM","dateCreated":"2018-02-13","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE98B7-4308-63DD-E053-731AD00A57C2","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"Other","valueDescription":null,"ValueMeaning":{"publicId":"6431768","version":"1","preferredName":"Other","longName":"6431768v1.00","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"762A692A-EEF7-29A1-E053-F662850A9EA9","latestVersionIndicator":"Yes","beginDate":"2018-09-18","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-09-18","modifiedBy":"GDEEN","dateModified":"2024-01-22","changeDescription":null,"administrativeNotes":"2023.2.1 Alt VM added per ticket request CADSR0001995. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE98B7-4309-63DD-E053-731AD00A57C2","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"Unknown","valueDescription":null,"ValueMeaning":{"publicId":"5682953","version":"1","preferredName":"Unknown","longName":"5682953","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B4645-0FC6-0802-E053-F662850AB305","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE98B7-430A-63DD-E053-731AD00A57C2","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"Not Reported","valueDescription":null,"ValueMeaning":{"publicId":"5612322","version":"1","preferredName":"Not Reported","longName":"5612322v1.00","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45340835-3B00-7C78-E053-F662850A44F9","latestVersionIndicator":"Yes","beginDate":"2017-01-03","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-01-03","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"10/10/23 changed Long Name from \"Not Stated\" to match NCIt Preferred name and current caDSR concept Long Name of \"Not Reported\" per Brenda.Janice . LS","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE98B7-430B-63DD-E053-731AD00A57C2","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"t(7;12)(q36;p13) HLXB9(MNX1)/ETV6(TEL)","valueDescription":null,"ValueMeaning":{"publicId":"13336612","version":"1","preferredName":"t(7;12)(q36;p13)","longName":"13336612v1.00","preferredDefinition":"A chromosomal translocation involving the ETV6 gene on chromosome 12p13 and HLXB9 gene on chromosome 7q36.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(7;12)(q36;p13)","conceptCode":"C122689","definition":"A chromosomal translocation involving the ETV6 gene on chromosome 12p13 and HLXB9 gene on chromosome 7q36.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE98B7-42FB-63DD-E053-731AD00A57C2","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE98B7-430C-63DD-E053-731AD00A57C2","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"t(11;15)(p15;q35)/NUP98/JARID1A","valueDescription":null,"ValueMeaning":{"publicId":"13336604","version":"1","preferredName":"t(11;15)(p15;q35)","longName":"13336604v1.00","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of chromosome 11p15 with chromosome 15q35. It results in the formation of NUP98/JARID1A fusion gene. It is associated with the development of acute myeloid leukemia with t(11;15)(p15;q35); NUP98-JARID1A.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(11;15)(p15;q35)","conceptCode":"C131505","definition":"A cytogenetic abnormality that refers to the translocation of chromosome 11p15 with chromosome 15q35. It results in the formation of NUP98/JARID1A fusion gene. It is associated with the development of acute myeloid leukemia with t(11;15)(p15;q35); NUP98-JARID1A.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE98B7-42F3-63DD-E053-731AD00A57C2","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE98B7-430D-63DD-E053-731AD00A57C2","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"t(11;17)(AF17)","valueDescription":null,"ValueMeaning":{"publicId":"13336605","version":"1","preferredName":"t(11;17)(q23;q12-21)","longName":"13336605v1.00","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of the long arm (q23) of chromosome 11 and the long arm (q12-21) of chromosome 19. It is associated with KMT2A (MLL) fusions, including those with MLLT6 (AF17), and acute myeloid leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(11;17)(q23;q12-21)","conceptCode":"C168760","definition":"A cytogenetic abnormality that refers to the translocation of the long arm (q23) of chromosome 11 and the long arm (q12-21) of chromosome 19. It is associated with KMT2A (MLL) fusions, including those with MLLT6 (AF17), and acute myeloid leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE98B7-42F4-63DD-E053-731AD00A57C2","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE98B7-430E-63DD-E053-731AD00A57C2","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"t(11;19)(q23;p13.1) (MLL-ELL)","valueDescription":null,"ValueMeaning":{"publicId":"13336606","version":"1","preferredName":"t(11;19)(q23;p13.1)","longName":"13336606v1.00","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of the long arm (q23) of chromosome 11 and the short arm (p13.1) of chromosome 19. It is associated with the development of acute myeloid leukemia with variant MLL translocations and topoisomerase II inhibitor-related acute myeloid leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(11;19)(q23.3;p13.1)","conceptCode":"C36371","definition":"A cytogenetic abnormality that refers to the translocation of the long arm (q23.3) of chromosome 11 and the short arm (p13.1) of chromosome 19. It is associated with the development of acute myeloid leukemia with variant MLL translocations and topoisomerase II inhibitor-related acute myeloid leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE98B7-42F5-63DD-E053-731AD00A57C2","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE98B7-430F-63DD-E053-731AD00A57C2","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"t(11;19)(q23;p13) (MLL-ENL)/(MLL-ELL)","valueDescription":null,"ValueMeaning":{"publicId":"13336607","version":"1","preferredName":"t(11;19)(q23;p13)","longName":"13336607v1.00","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of the long arm (q23) of chromosome 11 and the short arm (p13) of chromosome 19. It is associated with KMT2A (MLL) fusions, including those with MLLT1 (ENL) and ELL, and acute myeloid leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(11;19)(q23;p13)","conceptCode":"C168764","definition":"A cytogenetic abnormality that refers to the translocation of the long arm (q23) of chromosome 11 and the short arm (p13) of chromosome 19. It is associated with KMT2A (MLL) fusions, including those with MLLT1 (ENL) and ELL, and acute myeloid leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE98B7-42F6-63DD-E053-731AD00A57C2","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE98B7-4310-63DD-E053-731AD00A57C2","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"t(15;17)(q24;q21)","valueDescription":null,"ValueMeaning":{"publicId":"5219770","version":"1","preferredName":"t(15;17)(q22;q12)","longName":"5219770","preferredDefinition":"A chromosomal translocation associated with creation of a fusion between the PML and RARA genes. It is seen in variants of Acute Promyelocytic Leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(15;17)(q24;q21)","conceptCode":"C27758","definition":"A chromosomal translocation associated with creation of a fusion between the PML and RARA genes. It is seen in variants of acute promyelocytic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"305FB5C7-0ECA-4760-E050-BB89AD43474E","latestVersionIndicator":"Yes","beginDate":"2016-04-13","endDate":null,"createdBy":"COLBERTM","dateCreated":"2016-04-13","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE98B7-4311-63DD-E053-731AD00A57C2","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"t(16;16)(p13.1;q22)","valueDescription":null,"ValueMeaning":{"publicId":"4340487","version":"1","preferredName":"t(16;16)(p13.1;q22)","longName":"4340487","preferredDefinition":"A chromosomal translocation that involves chromosome 16. It is often associated with the development of acute myeloid leukemia CBFB-MYH11, acute myelomonocytic leukemia with abnormal eosinophils, and granulocytic sarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(16;16)(p13.1;q22)","conceptCode":"C27759","definition":"A chromosomal translocation that involves chromosome 16. It is often associated with the development of acute myeloid leukemia CBFB-MYH11, acute myelomonocytic leukemia with abnormal eosinophils, and granulocytic sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FADC8D24-9CD5-C9E3-E040-BB89AD4350B8","latestVersionIndicator":"Yes","beginDate":"2014-06-02","endDate":null,"createdBy":"COLBERTM","dateCreated":"2014-06-02","modifiedBy":"COLBERTM","dateModified":"2020-06-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE98B7-4312-63DD-E053-731AD00A57C2","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"t(16;21)(p11;q22)FUS/ERG","valueDescription":null,"ValueMeaning":{"publicId":"7292215","version":"1","preferredName":"t(16;21)(p11;q22)","longName":"7292215","preferredDefinition":"A chromosomal translocation involving the FUS gene on chromosome 16p11 and the ERG gene on chromosome 21q22.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(16;21)(p11;q22)","conceptCode":"C36616","definition":"A chromosomal translocation involving the FUS gene on chromosome 16p11 and the ERG gene on chromosome 21q22.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A58CF713-09BE-2632-E053-F662850ABD95","latestVersionIndicator":"Yes","beginDate":"2020-05-13","endDate":null,"createdBy":"COLBERTM","dateCreated":"2020-05-13","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE98B7-4313-63DD-E053-731AD00A57C2","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"t(16;21)(q24;q22)RUNX1-CBFA2T3","valueDescription":null,"ValueMeaning":{"publicId":"13336608","version":"1","preferredName":"t(16;21)(q24;q22)","longName":"13336608v1.00","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of the long arm (q24) of chromosome 16 and the long arm (q22) of chromosome 22. It is associated with RUNX1/CBFA2T3 fusions, myelodysplastic syndromes and acute myeloid leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(16;21)(q24;q22)","conceptCode":"C168773","definition":"A cytogenetic abnormality that refers to the translocation of the long arm (q24) of chromosome 16 and the long arm (q22) of chromosome 22. It is associated with RUNX1/CBFA2T3 fusions, myelodysplastic syndromes and acute myeloid leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE98B7-42F7-63DD-E053-731AD00A57C2","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE98B7-4314-63DD-E053-731AD00A57C2","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"t(2;12)","valueDescription":null,"ValueMeaning":{"publicId":"13336609","version":"1","preferredName":"t(2;12)","longName":"13336609v1.00","preferredDefinition":"A cytogenetic abnormality that involves a translocation between chromosomes 2 and 12.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(2;12)","conceptCode":"C173543","definition":"A cytogenetic abnormality that involves a translocation between chromosomes 2 and 12.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE98B7-42F8-63DD-E053-731AD00A57C2","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE98B7-4315-63DD-E053-731AD00A57C2","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"t(11;19)(q23;p13.3) (MLL-ENL)","valueDescription":null,"ValueMeaning":{"publicId":"7292213","version":"1","preferredName":"t(11;19)(q23.3;p13.3)","longName":"7292213","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of the long arm (q23.3) of chromosome 11 and the short arm (p13.3) of chromosome 19 and . It is associated with KMT2A (MLL)/MLLT10 fusions and acute myeloid leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(11;19)(q23.3;p13.3)","conceptCode":"C36372","definition":"A cytogenetic abnormality that refers to the translocation of the long arm (q23.3) of chromosome 11 and the short arm (p13.3) of chromosome 19. It is associated with KMT2A (MLL)/MLLT1 (ENL) fusions and acute myeloid leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A58CF713-0974-2632-E053-F662850ABD95","latestVersionIndicator":"Yes","beginDate":"2020-05-13","endDate":null,"createdBy":"COLBERTM","dateCreated":"2020-05-13","modifiedBy":"COLBERTM","dateModified":"2020-06-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8FE98B7-4316-63DD-E053-731AD00A57C2","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008571","version":"1","preferredName":"Chronic or Associated Diseases and Exposures","preferredDefinition":"chronic diseases, as well as diseases and exposures associated with cancer.","longName":"CHR_O_ASS_DZ_AND_EXP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9B9249B-AB81-2F8D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-03-25","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-03-25","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"10625882","version":"1","preferredName":"Biomarker Type","preferredDefinition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention._Something distinguishable as an identifiable class based on common qualities.","longName":"10625882v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biomarker","conceptCode":"C16342","definition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E41B5A2A-5F6B-01CA-E053-731AD00AD8B8","latestVersionIndicator":"Yes","beginDate":"2022-07-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-07-18","modifiedBy":"MMADDINENI","dateModified":"2022-07-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FDEA39-18AE-480E-E053-731AD00AF359","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-04-10","modifiedBy":"FINCHAMB","dateModified":"2023-11-14","changeDescription":null,"administrativeNotes":"11/14/23 Released per PCDC-U of Chicago/Mei Li. BF;7/24/23 Upd OC to Molecular Marker to remove MRD from VD semantics. mr;\r\n4/10/23 Created per PCDC metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"12173174","version":"1","longName":"PCDC Aggregated Dictionary","context":"Pediatric Cancer","ClassificationSchemeItems":[{"publicId":"12173180","version":"1","longName":"Response","context":"Pediatric Cancer"},{"publicId":"12173217","version":"1","longName":"Minimal Residual Disease","context":"Pediatric Cancer"}]}],"AlternateNames":[{"name":"MRD_MOLECULAR_MARKERS","type":"PCDC Alt Name","context":"Pediatric Cancer"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"MRD Molecular Markers","url":null,"context":"Pediatric Cancer"}],"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F98E4CB6-3D13-0CA8-E053-731AD00A7621","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-04-17","modifiedBy":"FINCHAMB","dateModified":"2023-11-14","changeDescription":null,"administrativeNotes":"11/14/23 Released per PCDC-U of Chicago/Mei Li. BF;7/24/23 Upd DEC and VD to remove Specimen from semantics. \r\n4/17/24 Curated for PCDC. BF","unresolvedIssues":null,"deletedIndicator":"No"}}